Insider Trading › AMRN › Insiders
AMARIN CORP PLC\UK
AMRN·Nasdaq·Insider activity
$12.07
-0.02 (-0.17%)
Close · Oct 6, 2026 · Close Prices from Tiingo.com
AMRN
Insider purchases and sales on the price
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
AMRNS&P 500 (rebased)
Insider BuyInsider SellForm 144 · planned sale
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair
No open-market insider purchases or sales of AMRN were filed in the last 180 days. Newest filing Aug 5, 2024 (2 years ago).
Net Insider Buying by Quarter
Shares bought (+) or sold (−) on the open market by AMRN insiders · Form 4 · last two years
No open-market insider buys or sells in the last two years.
On Record
$0Purchases · 180 days
$0Sales · 180 days
303Open-market transactions on record
0Insiders filing · 180 days
Purchases (code P) and sales (code S) of AMRN common stock reported on Form 4, with Form 5 annual catch-ups. Grants, option exercises, gifts and tax withholding are not shown. Dollars are shares × the stated price; a price outside anything the stock traded at that day is withheld (n/c).
Insider Transactions
303 on record · newest trade first · the newest 300 shown
AllPurchasesSalesOfficers & directors
| Insider | Type | Shares | Price | Value | Held after | Traded | Filed | |
|---|---|---|---|---|---|---|---|---|
| Berg AaronPresident and CEO | Purchase | +160.0K | $0.64 | $102K | 805.4Kdirect | Aug 2, 2024 | Aug 5, 2024 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +14.4K | $1.09 | $16K | 314.4Kdirect | Jan 22, 2024 | Jan 24, 2024 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −34.1K | $0.79 | $27K | 566.1Kdirect | Dec 12, 2023 | Dec 14, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +67.2K | $1.06 | $71K | 300.0Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +25.8K | $1.06 | $27K | 233.8Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +12.7K | $1.05 | $13K | 206.9Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +30.6K | $1.04 | $32K | 194.2Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +19.4K | $1.04 | $20K | 163.6Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +143.3K | $1.03 | $148K | 144.2Kdirect | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| Holt PatrickPresident and CEO · Director | Purchase | +958 | $1.03 | $987 | 958direct | Aug 16, 2023 | Aug 16, 2023 | Form 4 ↗ |
| WOLD OLSEN PERDirector | Purchase | +55.0K | $1.69 | $93K | 149.0Kdirect | Jun 13, 2022 | Jun 15, 2022 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +2,000 | $3.16 | $6K | 196.5Kdirect | Dec 15, 2021 | Dec 16, 2021 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Purchase | +10.0K | $3.27 | $33K | 194.5Kdirect | Dec 14, 2021 | Dec 16, 2021 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −120.0K | $5.25 | $630K | 205.0Kdirect | Aug 12, 2021 | Aug 13, 2021 | Form 4 ↗ |
| STACK DAVID MDirector | Purchase | +10.0K | $4.54 | $45K | 40.0Kindirect | Jun 4, 2021 | Jun 7, 2021 | Form 4 ↗ |
| STACK DAVID MDirector | Purchase | +5,000 | $4.62 | $23K | 30.0Kindirect | Jun 3, 2021 | Jun 7, 2021 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −25.4K | $8.03 | $204K | 383.0Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −192.4K | $8.06 | $1.6M | 408.4Kdirect | Feb 1, 2021 | Feb 3, 2021 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −143.4K | $8.01 | $1.1M | 388.1Kdirect | Jan 27, 2021 | Jan 29, 2021 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −278.2K | $8.01 | $2.2M | 531.5Kdirect | Jan 27, 2021 | Jan 29, 2021 | Form 4 ↗ |
| STACK DAVID MDirector | Purchase | +25.0K | $4.86 | $122K | 25.0Kindirect | Nov 30, 2020 | Dec 2, 2020 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −413.6K | $4.07 | $1.7M | 2.7Mdirect | Nov 11, 2020 | Nov 12, 2020 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −153.8K | $4.13 | $635K | 3.2Mdirect | Nov 10, 2020 | Nov 12, 2020 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −200.0K | $15.99 | $3.2M | 2.5Mdirect | Mar 4, 2020 | Mar 6, 2020 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −300.0K | $20.94 | $6.3M | 84.5Kdirect | Jan 3, 2020 | Jan 3, 2020 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −100.0K | $25.83 | $2.6M | 84.5Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Berg AaronCHIEF COMMERCIAL OFFICER | Sale | −43.3K | $25.46 | $1.1M | 133.8Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −100 | $25.66 | $3K | 21.6Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −1,000 | $24.84 | $25K | 21.7Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −7,500 | $23.81 | $179K | 22.7Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −16.4K | $23.05 | $378K | 30.2Kdirect | Dec 16, 2019 | Dec 18, 2019 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −274.5K | $22.65 | $6.2M | 2.3Mdirect | Nov 19, 2019 | Nov 21, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −38.6K | $19.35 | $747K | 0direct | Nov 12, 2019 | Nov 13, 2019 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −41.7K | $17.88 | $746K | 2.6Mdirect | Nov 11, 2019 | Nov 13, 2019 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −433.8K | $17.05 | $7.4M | 2.7Mdirect | Nov 11, 2019 | Nov 13, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −6,400 | $18.00 | $115K | 0direct | Nov 5, 2019 | Nov 7, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −91.0K | $15.01 | $1.4M | 0direct | Sep 3, 2019 | Sep 5, 2019 | Form 4 ↗ |
| STACK DAVID MDirector | Sale | −52.0K | $22.28 | $1.2M | 0indirect | Jul 11, 2019 | Jul 12, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −100.0K | $23.82 | $2.4M | 84.5Kdirect | Jul 5, 2019 | Jul 5, 2019 | Form 4 ↗ |
| Berg AaronCHIEF COMMERCIAL OFFICER | Sale | −29.3K | $22.64 | $662K | 36.4Kdirect | Jul 3, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Berg AaronCHIEF COMMERCIAL OFFICER | Sale | −19.6K | $21.42 | $419K | 36.4Kdirect | Jul 2, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Berg AaronCHIEF COMMERCIAL OFFICER | Sale | −50.0K | $20.46 | $1.0M | 55.9Kdirect | Jul 2, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −54.2K | $19.52 | $1.1M | 31.3Kdirect | Jul 1, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −50.0K | $19.67 | $984K | 20.8Kdirect | Jul 1, 2019 | Jul 3, 2019 | Form 4 ↗ |
| Berg AaronCHIEF COMMERCIAL OFFICER | Sale | −113.2K | $18.59 | $2.1M | 36.4Kdirect | Jun 24, 2019 | Jun 26, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −100.0K | $19.02 | $1.9M | 84.5Kdirect | Jun 18, 2019 | Jun 20, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −27.2K | $17.92 | $488K | 31.3Kdirect | May 31, 2019 | May 31, 2019 | Form 4 ↗ |
| STACK DAVID MDirector | Sale | −33.8K | $18.45 | $624K | 0direct | May 29, 2019 | May 31, 2019 | Form 4 ↗ |
| STACK DAVID MDirector | Sale | −13.2K | $18.00 | $237K | 0direct | May 17, 2019 | May 21, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −9,541 | $18.67 | $178K | 354.5Kdirect | Apr 30, 2019 | May 2, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −27.2K | $18.69 | $509K | 31.3Kdirect | Apr 30, 2019 | May 2, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100 | $20.78 | $2K | 354.5Kdirect | Apr 1, 2019 | Apr 1, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −9,442 | $20.05 | $189K | 354.6Kdirect | Apr 1, 2019 | Apr 1, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | +1,112 | $20.80 | $23K | 31.3Kdirect | Apr 1, 2019 | Apr 1, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −53.1K | $20.03 | $1.1M | 32.4Kdirect | Apr 1, 2019 | Apr 1, 2019 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −70.7K | $21.70 | $1.5M | 2.1Mdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −179.3K | $21.15 | $3.8M | 2.2Mdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −36.7K | $21.71 | $797K | 0direct | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −98.7K | $21.16 | $2.1M | 36.7Kdirect | Mar 4, 2019 | Mar 6, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −7,099 | $22.64 | $161K | 354.5Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −35.4K | $22.10 | $782K | 361.6Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −3,503 | $20.94 | $73K | 397.0Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −22.1K | $22.59 | $499K | 20.6Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −70.8K | $22.06 | $1.6M | 42.6Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −7,124 | $20.89 | $149K | 113.4Kdirect | Mar 1, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −9,543 | $20.67 | $197K | 354.5Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −27.2K | $20.72 | $564K | 31.3Kdirect | Feb 28, 2019 | Mar 1, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −180.6K | $19.90 | $3.6M | 84.5Kdirect | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| VAN HEEK G JANDirector | Sale | −203.4K | $20.02 | $4.1M | 14.2Kdirect | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| Peterson KristineDirector | Sale | −163.5K | $20.02 | $3.3M | 0direct | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −50.0K | $18.97 | $949K | 20.6Kdirect | Feb 22, 2019 | Feb 22, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −25.0K | $17.58 | $439K | 20.6Kdirect | Feb 15, 2019 | Feb 15, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −28.0K | $17.06 | $477K | 354.5Kdirect | Feb 1, 2019 | Feb 1, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −9,541 | $17.49 | $167K | 341.3Kdirect | Jan 31, 2019 | Feb 1, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −42.6K | $17.49 | $745K | 31.3Kdirect | Jan 31, 2019 | Feb 1, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −609.1K | $17.66 | $10.8M | 0direct | Jan 24, 2019 | Jan 24, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −255.8K | $17.95 | $4.6M | 217.9Kdirect | Jan 23, 2019 | Jan 24, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −175.3K | $17.92 | $3.1M | 217.9Kdirect | Jan 22, 2019 | Jan 24, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −3,173 | $18.92 | $60K | 217.9Kdirect | Jan 11, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −100.0K | $17.96 | $1.8M | 84.5Kdirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −100.0K | $16.00 | $1.6M | 184.5Kdirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| STACK DAVID MDirector | Sale | −98.6K | $18.00 | $1.8M | 0indirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| STACK DAVID MDirector | Sale | −26.9K | $18.00 | $485K | 0direct | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −7,496 | $18.62 | $140K | 0direct | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −55.8K | $18.16 | $1.0M | 7,496direct | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −48.7K | $17.29 | $842K | 63.3Kdirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −7,247 | $15.96 | $116K | 112.0Kdirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Ekman LarsDirector | Sale | −21.2K | $14.92 | $316K | 119.2Kdirect | Jan 10, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −200.0K | $15.26 | $3.1M | 17.5Kdirect | Jan 9, 2019 | Jan 11, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −385.0K | $13.03 | $5.0M | 84.5Kdirect | Jan 2, 2019 | Jan 2, 2019 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −26.9K | $13.49 | $363K | 217.9Kdirect | Dec 31, 2018 | Jan 2, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −17.0K | $13.51 | $230K | 341.3Kdirect | Dec 31, 2018 | Jan 2, 2019 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −141.5K | $13.19 | $1.9M | 84.5Kdirect | Dec 28, 2018 | Jan 2, 2019 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −17.0K | $17.79 | $303K | 341.3Kdirect | Nov 30, 2018 | Nov 30, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −23.3K | $17.81 | $415K | 217.9Kdirect | Nov 30, 2018 | Nov 30, 2018 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −5,000 | $20.72 | $104K | 2.1Mdirect | Nov 12, 2018 | Nov 14, 2018 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −222.2K | $19.71 | $4.4M | 2.1Mdirect | Nov 12, 2018 | Nov 14, 2018 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −244.0K | $19.03 | $4.6M | 2.3Mdirect | Nov 12, 2018 | Nov 14, 2018 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Sale | −136.4K | $18.05 | $2.5M | 2.6Mdirect | Nov 12, 2018 | Nov 14, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −500 | $21.39 | $11K | 341.3Kdirect | Oct 31, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −16.5K | $20.72 | $343K | 341.8Kdirect | Oct 31, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −600 | $21.37 | $13K | 217.9Kdirect | Oct 31, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −22.7K | $20.72 | $470K | 218.5Kdirect | Oct 31, 2018 | Nov 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −116.6K | $17.20 | $2.0M | 341.3Kdirect | Oct 1, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −8,400 | $17.99 | $151K | 217.9Kdirect | Oct 1, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −8,800 | $17.47 | $154K | 226.3Kdirect | Oct 1, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −33.0K | $16.33 | $540K | 235.1Kdirect | Oct 1, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100.0K | $16.00 | $1.6M | 341.3Kdirect | Sep 28, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100.0K | $15.00 | $1.5M | 441.3Kdirect | Sep 28, 2018 | Oct 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100.0K | $14.00 | $1.4M | 341.3Kdirect | Sep 25, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100.0K | $13.00 | $1.3M | 441.3Kdirect | Sep 25, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −65.8K | $12.18 | $801K | 226.0Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −26.9K | $11.23 | $303K | 291.8Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Zakrzewski Joseph SDirector | Sale | −407.3K | $10.30 | $4.2M | 318.8Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −100.0K | $12.00 | $1.2M | 341.3Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −49.5K | $10.94 | $541K | 441.3Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −529.8K | $10.04 | $5.3M | 490.7Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −139.7K | $12.14 | $1.7M | 217.9Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −55.2K | $11.14 | $615K | 357.6Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −884.8K | $10.27 | $9.1M | 412.8Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −70.2K | $10.72 | $753K | 15.0Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kalb Michael WayneSVP and CFO | Sale | −79.8K | $10.15 | $810K | 85.2Kdirect | Sep 24, 2018 | Sep 26, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −26.9K | $3.00 | $81K | 18.4Kdirect | Jul 2, 2018 | Jul 3, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −19.0K | $2.89 | $55K | 18.4Kdirect | Apr 3, 2018 | Apr 3, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −7,900 | $2.91 | $23K | 37.5Kdirect | Apr 2, 2018 | Apr 3, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −44.9K | $3.73 | $167K | 18.4Kdirect | Jan 31, 2018 | Feb 2, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −135.2K | $4.41 | $596K | 141.8Kdirect | Jan 23, 2018 | Jan 23, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −31.5K | $4.03 | $127K | 0direct | Jan 17, 2018 | Jan 17, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −10.0K | $4.13 | $41K | 31.5Kdirect | Jan 16, 2018 | Jan 17, 2018 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −9,587 | $4.29 | $41K | 41.5Kdirect | Jan 12, 2018 | Jan 17, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −2,612 | $4.40 | $11K | 141.8Kdirect | Jan 11, 2018 | Jan 16, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −64.7K | $4.40 | $285K | 141.8Kdirect | Jan 5, 2018 | Jan 9, 2018 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −128.3K | $4.25 | $545K | 141.8Kdirect | Jan 2, 2018 | Jan 4, 2018 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Purchase | +10.0K | $3.24 | $32K | 1.1Mdirect | Nov 30, 2017 | Dec 4, 2017 | Form 4 ↗ |
| Ketchum Steven BChief Scientific Officer | Sale | −63.5K | $3.48 | $221K | 141.8Kdirect | Oct 5, 2017 | Oct 6, 2017 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −51.1K | $4.09 | $209K | 0direct | Jul 3, 2017 | Jul 3, 2017 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −105.0K | $3.98 | $418K | 51.1Kdirect | Jun 30, 2017 | Jul 3, 2017 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −151.8K | $3.98 | $604K | 130.6Kdirect | Jun 29, 2017 | Jul 3, 2017 | Form 4 ↗ |
| Kennedy Joseph TGeneral Counsel | Sale | −122.4K | $3.04 | $372K | 162.1Kdirect | Nov 9, 2016 | Nov 10, 2016 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Purchase | +25.0K | $1.37 | $34K | 661.7Kdirect | Feb 1, 2016 | Feb 3, 2016 | Form 4 ↗ |
| THERO JOHN FPresident and CEO · Director | Purchase | +20.0K | $2.35 | $47K | 304.4Kdirect | Aug 11, 2015 | Aug 11, 2015 | Form 4 ↗ |
| THERO JOHN FPresident, Chief Exec. Officer · Director | Purchase | +20.0K | $0.88 | $18K | 114.9Kdirect | Nov 12, 2014 | Nov 12, 2014 | Form 4 ↗ |
| Farrell Michael JamesController | Purchase | +5,500 | $0.84 | $5K | 6,037direct | Nov 11, 2014 | Nov 12, 2014 | Form 4 ↗ |
| THERO JOHN FPresident, Chief Exec. Officer · Director | Purchase | +30.0K | $0.80 | $24K | 94.9Kdirect | Nov 11, 2014 | Nov 12, 2014 | Form 4 ↗ |
| Ekman LarsDirector | Purchase | +40.0K | $1.80 | $72K | 40.0Kdirect | Nov 20, 2013 | Nov 20, 2013 | Form 4 ↗ |
| THERO JOHN FPresident | Purchase | +5,000 | $1.90 | $10K | 64.9Kdirect | Nov 20, 2013 | Nov 20, 2013 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Purchase | +50.8K | $1.54 | $78K | 226.0Kdirect | Nov 18, 2013 | Nov 18, 2013 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −150.0K | $12.56 | $1.9M | 111.9Kdirect | Oct 1, 2012 | Oct 3, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −2,244 | $14.43 | $32K | 5,700indirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −231.5K | $14.43 | $3.3M | 594.3Kindirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −2,244 | $14.43 | $32K | 5,700indirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −231.5K | $14.43 | $3.3M | 594.3Kindirect | Sep 4, 2012 | Sep 5, 2012 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −78.1K | $14.07 | $1.1M | 111.9Kdirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −71.9K | $14.58 | $1.0M | 190.0Kdirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| THERO JOHN FPresident | Sale | −150.0K | $13.71 | $2.1M | 9,450direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| THERO JOHN FPresident | Sale | −150.9K | $14.97 | $2.3M | 9,450direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Kennedy Joseph TSenior VP and General Counsel | Sale | −6,409 | $13.78 | $88K | 0direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Kennedy Joseph TSenior VP and General Counsel | Sale | −541 | $14.74 | $8K | 6,409direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −6,409 | $13.78 | $88K | 0direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −541 | $14.74 | $8K | 6,409direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| SEDLACK STUART DSenior Vice President | Sale | −6,409 | $13.78 | $88K | 0direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| SEDLACK STUART DSenior Vice President | Sale | −541 | $14.74 | $8K | 6,409direct | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −3,456 | $14.61 | $50K | 7,944indirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −362.8K | $14.61 | $5.3M | 825.8Kindirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −3,456 | $14.61 | $50K | 7,944indirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −362.8K | $14.61 | $5.3M | 825.8Kindirect | Jul 27, 2012 | Jul 30, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −48.9K | $15.01 | $734K | 0direct | Jun 27, 2012 | Jun 27, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −1,100 | $13.52 | $15K | 0direct | Jun 26, 2012 | Jun 27, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −5,900 | n/c | — | 11.4Kindirect | Jun 19, 2012 | Jun 19, 2012 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −611.2K | $12.91 | $7.9M | 1.2Mindirect | Jun 19, 2012 | Jun 19, 2012 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −5,900 | $12.91 | $76K | 11.4Kindirect | Jun 19, 2012 | Jun 19, 2012 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −611.2K | $12.91 | $7.9M | 1.2Mindirect | Jun 19, 2012 | Jun 19, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −162.9K | $12.00 | $2.0M | 0direct | Jun 18, 2012 | Jun 19, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −100 | $12.00 | $1K | 0direct | Jun 15, 2012 | Jun 19, 2012 | Form 4 ↗ |
| Huff PaulChief Commercial Officer | Sale | −16.7K | $12.06 | $202K | 0direct | Jun 7, 2012 | Jun 8, 2012 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −150.0K | $11.97 | $1.8M | 78.6Kdirect | May 29, 2012 | May 31, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale Amended | −682.0K | $9.66 | $6.6M | 1.6Mindirect | Apr 19, 2012 | Apr 26, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −682.0K | $9.66 | $6.6M | 1.6Mindirect | Apr 19, 2012 | Apr 19, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale Amended | −1.6M | $9.60 | $15.5M | 2.3Mindirect | Apr 18, 2012 | Apr 26, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −1.6M | $9.60 | $15.5M | 2.3Mindirect | Apr 18, 2012 | Apr 19, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale Amended | −1.7M | $9.61 | $16.5M | 3.9Mindirect | Apr 17, 2012 | Apr 26, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −1.7M | $9.61 | $16.5M | 3.9Mindirect | Apr 17, 2012 | Apr 19, 2012 | Form 4 ↗ |
| THERO JOHN FPresident | Sale | −150.9K | $9.96 | $1.5M | 0direct | Apr 9, 2012 | Apr 11, 2012 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −2.3M | $11.00 | $25.3M | 5.6Mindirect | Apr 3, 2012 | Apr 5, 2012 | Form 4 ↗ |
| HEALY JAMESDirector | Sale | −1.0M | $10.98 | $11.0M | 5.5Mindirect | Apr 3, 2012 | Apr 4, 2012 | Form 4 ↗ |
| HEALY JAMESDirector | Sale | −735.6K | $10.98 | $8.1M | 6.5Mindirect | Apr 3, 2012 | Apr 4, 2012 | Form 4 ↗ |
| HEALY JAMESDirector | Sale | −264.4K | $10.99 | $2.9M | 7.2Mindirect | Apr 2, 2012 | Apr 4, 2012 | Form 4 ↗ |
| HEALY JAMESDirector | Sale | −993.7K | $10.98 | $10.9M | 7.5Mindirect | Mar 29, 2012 | Mar 30, 2012 | Form 4 ↗ |
| HEALY JAMESDirector | Sale | −6,302 | $11.73 | $74K | 8.5Mindirect | Mar 28, 2012 | Mar 30, 2012 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −160.0K | $11.59 | $1.9M | 78.6Kdirect | Mar 23, 2012 | Mar 27, 2012 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −300 | $16.30 | $5K | 17.3Kindirect | May 2, 2011 | May 3, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −32.6K | $16.30 | $531K | 1.8Mindirect | May 2, 2011 | May 3, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −300 | $16.30 | $5K | 17.3Kindirect | May 2, 2011 | May 3, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −32.6K | $16.30 | $531K | 1.8Mindirect | May 2, 2011 | May 3, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −1,000 | $16.01 | $16K | 17.6Kindirect | Apr 29, 2011 | May 3, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −99.0K | $16.01 | $1.6M | 1.8Mindirect | Apr 29, 2011 | May 3, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −1,000 | $16.01 | $16K | 17.6Kindirect | Apr 29, 2011 | May 3, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −99.0K | $16.01 | $1.6M | 1.8Mindirect | Apr 29, 2011 | May 3, 2011 | Form 4 ↗ |
| VAN HEEK G JANDirector | Sale | −30.0K | $16.58 | $497K | 16.3Kdirect | Apr 25, 2011 | Apr 27, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −4,733 | $16.91 | $80K | 18.6Kindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −495.3K | $16.91 | $8.4M | 1.9Mindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −2,367 | $16.18 | $38K | 23.3Kindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −247.6K | $16.18 | $4.0M | 2.4Mindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −4,733 | $16.91 | $80K | 18.6Kindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −495.3K | $16.91 | $8.4M | 1.9Mindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −2,367 | $16.18 | $38K | 23.3Kindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −247.6K | $16.18 | $4.0M | 2.4Mindirect | Apr 21, 2011 | Apr 25, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale Amended | −7,600 | $15.79 | $120K | 25.7Kindirect | Apr 20, 2011 | Apr 26, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale Amended | −792.4K | $15.79 | $12.5M | 2.7Mindirect | Apr 20, 2011 | Apr 26, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale Amended | −7,600 | $15.79 | $120K | 25.7Kindirect | Apr 20, 2011 | Apr 26, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale Amended | −792.4K | $15.79 | $12.5M | 2.7Mindirect | Apr 20, 2011 | Apr 26, 2011 | Form 4 ↗ |
| Ahlholm Frederick WVice President Finance | Sale | −31.3K | $15.88 | $496K | 0direct | Apr 20, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −7,600 | $15.79 | $120K | 25.7Kindirect | Apr 20, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −792.4K | $15.79 | $12.5M | 2.7Mindirect | Apr 20, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −7,600 | $15.79 | $120K | 25.7Kindirect | Apr 20, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −792.4K | $15.79 | $12.5M | 2.7Mindirect | Apr 20, 2011 | Apr 20, 2011 | Form 4 ↗ |
| Soni PareshSVP and Head of Development | Sale | −80.0K | $15.11 | $1.2M | 0direct | Apr 19, 2011 | Apr 20, 2011 | Form 4 ↗ |
| VAN HEEK G JANDirector | Sale Amended | −3,000 | n/c | — | 16.3Kdirect | Apr 18, 2011 | Apr 27, 2011 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −300.0K | $15.76 | $4.7M | 63.6Kdirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| VAN HEEK G JANDirector | Sale | −3,000 | $16.51 | $50K | 19.3Kdirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −4.2M | $14.87 | $62.1M | 7.9Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −10 | $16.26 | $163 | 33.3Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −1,102 | $16.26 | $18K | 3.5Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −11.5K | $15.65 | $180K | 33.3Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −1.2M | $15.65 | $19.0M | 3.5Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −16.7K | $14.86 | $248K | 44.8Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −1.8M | $14.86 | $26.1M | 4.7Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −10 | $16.26 | $163 | 33.3Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −1,102 | $16.26 | $18K | 3.5Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −11.5K | $15.65 | $180K | 33.3Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −1.2M | $15.65 | $19.0M | 3.5Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −16.7K | $14.86 | $248K | 44.8Kindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| ISALY SAMUEL DDirector | Sale | −1.8M | $14.86 | $26.1M | 4.7Mindirect | Apr 18, 2011 | Apr 20, 2011 | Form 4 ↗ |
| Ahlholm Frederick WVice President Finance | Sale | −31.3K | $7.48 | $234K | 0direct | Apr 4, 2011 | Apr 6, 2011 | Form 4 ↗ |
| HEALY JAMESDirector · 10% owner | Sale | −424.9K | $7.25 | $3.1M | 8.5Mdirect | Mar 29, 2011 | Mar 31, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −900 | $7.35 | $7K | 61.5Kindirect | Mar 28, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −92.2K | $7.35 | $678K | 6.4Mindirect | Mar 28, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −900 | $7.35 | $7K | 61.5Kindirect | Mar 28, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −92.2K | $7.35 | $678K | 6.4Mindirect | Mar 28, 2011 | Mar 28, 2011 | Form 4 ↗ |
| HEALY JAMESDirector · 10% owner | Sale | −75.1K | $7.50 | $563K | 8.9Mdirect | Mar 25, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −500 | $7.47 | $4K | 62.4Kindirect | Mar 25, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −56.4K | $7.47 | $421K | 6.5Mindirect | Mar 25, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −500 | $7.47 | $4K | 62.4Kindirect | Mar 25, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −56.4K | $7.47 | $421K | 6.5Mindirect | Mar 25, 2011 | Mar 28, 2011 | Form 4 ↗ |
| HEALY JAMESDirector · 10% owner | Sale | −500.0K | $7.56 | $3.8M | 9.0Mdirect | Mar 24, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −200 | $7.50 | $2K | 62.9Kindirect | Mar 24, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −22.8K | $7.50 | $171K | 6.6Mindirect | Mar 24, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −200 | $7.50 | $2K | 62.9Kindirect | Mar 24, 2011 | Mar 28, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −22.8K | $7.50 | $171K | 6.6Mindirect | Mar 24, 2011 | Mar 28, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −700 | $7.05 | $5K | 63.1Kindirect | Mar 21, 2011 | Mar 23, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −76.3K | $7.05 | $538K | 6.6Mindirect | Mar 21, 2011 | Mar 23, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −700 | $7.05 | $5K | 63.1Kindirect | Mar 21, 2011 | Mar 23, 2011 | Form 4 ↗ |
| ORBIMED ADVISORS LLCDirector | Sale | −76.3K | $7.05 | $538K | 6.6Mindirect | Mar 21, 2011 | Mar 23, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −500 | $7.24 | $4K | 63.8Kindirect | Mar 15, 2011 | Mar 15, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −49.5K | $7.24 | $358K | 6.7Mindirect | Mar 15, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −500 | $7.24 | $4K | 63.8Kindirect | Mar 15, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −49.5K | $7.24 | $358K | 6.7Mindirect | Mar 15, 2011 | Mar 15, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −700 | $7.33 | $5K | 64.3Kindirect | Mar 14, 2011 | Mar 15, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −74.3K | $7.33 | $545K | 6.7Mindirect | Mar 14, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −700 | $7.33 | $5K | 64.3Kindirect | Mar 14, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −74.3K | $7.33 | $545K | 6.7Mindirect | Mar 14, 2011 | Mar 15, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −2.8M | $7.50 | $20.6M | 12.1Mindirect | Mar 11, 2011 | Mar 15, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −900 | $7.43 | $7K | 65.0Kindirect | Mar 11, 2011 | Mar 15, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −99.1K | $7.43 | $736K | 6.8Mindirect | Mar 11, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −900 | $7.43 | $7K | 65.0Kindirect | Mar 11, 2011 | Mar 15, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −99.1K | $7.43 | $736K | 6.8Mindirect | Mar 11, 2011 | Mar 15, 2011 | Form 4 ↗ |
| Buatois Eric10% owner | Sale | −2.0M | $7.50 | $15.0M | 9.5Mdirect | Mar 11, 2011 | Mar 14, 2011 | Form 4 ↗ |
| SOFINNOVA VENTURE PARTNERS VII L P10% owner | Sale | −606.3K | $7.26 | $4.4M | 11.5Mdirect | Mar 10, 2011 | Mar 11, 2011 | Form 4 ↗ |
| SOFINNOVA VENTURE PARTNERS VII L P10% owner | Sale | −30.7K | $7.25 | $223K | 12.1Mdirect | Mar 9, 2011 | Mar 11, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −550.0K | $7.50 | $4.1M | 14.8Mindirect | Mar 8, 2011 | Mar 10, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −200 | $7.68 | $2K | 65.9Kindirect | Mar 7, 2011 | Mar 7, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −24.8K | $7.68 | $190K | 6.9Mindirect | Mar 7, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −200 | $7.68 | $2K | 65.9Kindirect | Mar 7, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −24.8K | $7.68 | $190K | 6.9Mindirect | Mar 7, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −100.0K | $7.60 | $760K | 15.4Mindirect | Mar 4, 2011 | Mar 8, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −400 | $7.62 | $3K | 66.1Kindirect | Mar 4, 2011 | Mar 7, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −42.6K | $7.62 | $325K | 6.9Mindirect | Mar 4, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −400 | $7.62 | $3K | 66.1Kindirect | Mar 4, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −42.6K | $7.62 | $325K | 6.9Mindirect | Mar 4, 2011 | Mar 7, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −100 | $7.76 | $776 | 66.5Kindirect | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −6,900 | $7.76 | $54K | 7.0Mindirect | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −100 | $7.76 | $776 | 66.5Kindirect | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −6,900 | $7.76 | $54K | 7.0Mindirect | Mar 3, 2011 | Mar 7, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −1.2M | $7.70 | $9.2M | 15.5Mindirect | Mar 2, 2011 | Mar 4, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −900 | $7.72 | $7K | 66.6Kindirect | Mar 2, 2011 | Mar 2, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −94.1K | $7.72 | $726K | 7.0Mindirect | Mar 2, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −900 | $7.72 | $7K | 66.6Kindirect | Mar 2, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −94.1K | $7.72 | $726K | 7.0Mindirect | Mar 2, 2011 | Mar 2, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −50.0K | $7.61 | $381K | 16.7Mindirect | Mar 1, 2011 | Mar 2, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −500 | $7.56 | $4K | 67.5Kindirect | Mar 1, 2011 | Mar 2, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −49.5K | $7.56 | $374K | 7.1Mindirect | Mar 1, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −500 | $7.56 | $4K | 67.5Kindirect | Mar 1, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −49.5K | $7.56 | $374K | 7.1Mindirect | Mar 1, 2011 | Mar 2, 2011 | Form 4 ↗ |
| Abingworth LLP10% owner | Sale | −275.0K | $7.92 | $2.2M | 16.7Mindirect | Feb 28, 2011 | Mar 2, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −900 | $7.73 | $7K | 68.0Kindirect | Feb 28, 2011 | Mar 2, 2011 | Form 4 ↗ |
| OrbiMed Capital GP III LLCDirector | Sale | −99.1K | $7.73 | $766K | 7.1Mindirect | Feb 28, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −900 | $7.73 | $7K | 68.0Kindirect | Feb 28, 2011 | Mar 2, 2011 | Form 4 ↗ |
| GORDON CARL LDirector | Sale | −99.1K | $7.73 | $766K | 7.1Mindirect | Feb 28, 2011 | Mar 2, 2011 | Form 4 ↗ |
| Sofinnova Management VII, L.L.C.10% owner | Sale | −363.0K | $8.13 | $3.0M | 12.2Mdirect | Feb 25, 2011 | Mar 1, 2011 | Form 4 ↗ |
| Zakrzewski Joseph SChief Executive Officer · Director | Sale | −10.0K | $8.16 | $82K | 53.6Kdirect | Feb 25, 2011 | Feb 28, 2011 | Form 4 ↗ |
Source: SEC EDGAR Form 4 and Form 5 filings, SEC's quarterly bulk dataset through Jun 30, 2026, and KeyVex's half-hourly read of new filings since. Every row links its filing. Amendments are marked. Nothing here is a recommendation. All insider activity, market-wide →